Document is current
Any future updates will be listed below
-
Authors
Reiter, Gregor S. https://orcid.org/0000-0001-7661-4015
Borrelli, Enrico
Dolz-Marco, Rosa
Iezzi, Raymond
Bakri, Sophie J.
- License Information
-
More Information
Article History
Received: 5 April 2025
Accepted: 23 April 2025
First Online: 5 May 2025
Declarations
:
: Gregor S. Reiter: consultant for Apellis, Bayer, Boehringer Ingelheim, Espansione, Nordic Pharma, and Roche and received research support from RetInSight. Enrico Borrelli: consultant for Abbvie, Bayer, Hofmann La Roche, and Zeiss. Rosa Dolz-Marco: consultant for Heidelberg Engineering and received research support from Roche, Apellis, and IvericBio. Raymond Iezzi: consultant for Johnson & Johnson. Sophie J. Bakri: consultant for Abbvie, Adverum, Allergan, Amgen, Annexon, Apellis, Aviceda, Cholgene, Eyepoint, ilumen, Iveric bio, Kala, Genentech, La Science Neurotech, Novartis, Ocular Therapeutix, Opthea, Outlook, Pixium, Regenxbio, Regeneron, Rejuvitas, Revana, Roche, VoxelCloud, and Zeiss and research support from Lowy Medical Foundation and Regenxbio.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
